Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Study of Tranexamic Acid in Total Hip Replacement
2018-004552-37Phase 2Active
- Sponsor
- CHU Saint-Etienne
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tranexamic acid in Hip arthritis (3 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Percentage of hemoglobin decrease in the perioperative period. Started Apr 2019; status: active.
02
Drugs
tranexamic acid
03
Conditions
Hip arthritis
Beyond the preview
Go deeper on 2018-004552-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004552-37.